| Literature DB >> 31969010 |
Maximilienne Ascension Nyegue1, Alian Désiré Afagnigni1, Youchahou Njankouo Ndam1, Steve Valdi Djova1, Marie Christine Fonkoua2, François-Xavier Etoa1.
Abstract
Herbal products from Paullinia pinnata Linn are widely used in African folk medicine to treat several infectious diseases. Although the extracts from this plant has been shown to possess antimicrobial potential, their activity in infectious diarrhea is less reported. Diarrhea was induced by oral administration of 1.2 × 109 CFU/mL of Shigella flexneri to the rats. The infected rats were treated for 5 days with the doses of 111.42, 222.84, and 445.68 mg/kg of P pinnata. The level of biochemical parameters was assessed and histology of organs examined by 14 days subacute toxicity. S flexneri stool load was considerably reduced after 4 days of treatment with the dose of 445.68 mg/kg, 5 days at the dose of 222.84 mg/kg for the extract, and 2 days with ciprofloxacin. The dose of 111.42 mg/kg appeared efficient after 5 days of treatment. The creatinine level increased at the dose of 445.68 mg/kg in both male and female rats and decrease at the dose of 222.84 mg/mL in female rats while an increase was noted in the male rats. Liver and kidney histology were modified at the dose of 445.68 mg/kg while no change was observed at the doses of 111.42 and 222.84 mg/kg. P pinnata leaf extract is efficient against infectious diarrhea at 111.42 mg/kg without side effect.Entities:
Keywords: Paullinia pinnata; biochemical parameters; histological examination; infectious diarrhea; subacute toxicity
Mesh:
Substances:
Year: 2020 PMID: 31969010 PMCID: PMC6978825 DOI: 10.1177/2515690X19900883
Source DB: PubMed Journal: J Evid Based Integr Med ISSN: 2515-690X
Figure 1.Variation of Shigella flexneri load in stools of treated and untreated rats during treatment. Rats were treated for 5 days with 111.42 mg/kg, 222.84 mg/kg, and 445.68 mg/kg of ethanolic extract of Paullinia pinnata or ciprofloxacin. Data are presented as mean ± SEM (n = 6). Significant difference: *P < .05 compared with negative control; a P < .05 compared with positive control; b P < .05 compared with initial point; day 1: diarrhea appearance and treatment start.
Variation of Body Weight Gain (g) for Treated and Untreated Rats During Treatment.a
| Sex | Dose (mg/kg) | Body Weight (g) | % Weight Gain | ||
|---|---|---|---|---|---|
| Day 0 | Day 7 | Day 14 | |||
| Female | 0 | 164.8 ± 1.76 | 176 ± 1.78 | 184.8 ± 0.74 | 12.13 |
| 111.42 | 158.84 ± 2.5 | 171.28 ± 2.3 | 183.25 ± 1.26 | 15.36* | |
| 222.84 | 171.6 ± 1.52 | 183.2 ± 1.58 | 187.6 ± 2.32 | 09.32* | |
| 445.68 | 160.8 ± 2.63 | 170.8 ± 2.19 | 176 ± 0.98 | 09.45* | |
| Male | 0 | 159 ± 1.84 | 173.5 ± 1.26 | 186.15 ± 2.28 | 17.07 |
| 111.42 | 168 ± 0.80 | 179.3 ± 1.42 | 186.2 ± 1.72 | 10.83* | |
| 222.84 | 168 ± 2.41 | 177.2 ± 2.54 | 180.9 ± 1.57 | 07.67* | |
| 445.68 | 156.2 ± 1.89 | 168 ± 0.74 | 174.5 ± 1.65 | 11.71* | |
a The results are mean ± standard error of the mean (SEM) (n = 5). Data in the same column in the same sex with asterisk (*) are significantly different (P < .05) when compared with the control.
Effects of the Ethanolic Extract of Paullinia pinnata on Biochemical Parameters.a
| Sex | Dose (mg/kg) | ALT (U/L) | AST (U/L) | TP (g/L) | GSH (g/L) | Crea (g/L) |
|---|---|---|---|---|---|---|
| Female | 0 | 9.32 ± 0.24 | 20.52 ± 1.23 | 40.64 ± 1.21 | 0.026 ± 0.00 | 0.41 ± 0.03 |
| 111.42 | 9.21 ± 0.37 | 19.84 ± 1.32 | 39.42 ± 0.94 | 0.024 ± 0.00 | 0.42 ± 0.00 | |
| 222.84 | 9.13 ± 0.11 | 20.85 ± 0.31 | 40.15 ± 0.26 | 0.021 ± 0.00 | 0.34 ± 0.01* | |
| 445.68 | 10.77 ± 0.21 | 21.34 ± 0.12 | 39.78 ± 0.22 | 0.027 ± 0.00 | 0.80 ± 0.03* | |
| Male | 0 | 9 ± 0.66 | 16.22 ± 1.32 | 39 ± 0.33 | 0.024 ± 0.00 | 0.38 ± 0.00 |
| 111.42 | 8.78 ± 1.33 | 15 ± 0.92 | 39.38 ± 0.77 | 0.026 ± 0.00 | 0.36 ± 0.01 | |
| 222.84 | 9.01 ± 0.7 | 14.93 ± 1.02 | 38.31 ± 0.51 | 0.027 ± 0.00 | 0.62 ± 0.03* | |
| 445.68 | 10.39 ± 0.7 | 18.25 ± 1.99 | 43.15 ± 1.84 | 0.024 ± 0.00 | 1.03 ± 0.03* |
Abbreviations: ALT, alanine aminotransferase; AST, aspartate aminotransferase; TP, total proteins; GSH, glutathione; Crea, creatinine.
a The results are mean ± standard error of the mean (SEM) (n = 5). Data in the same column in the same sex with asterisk (*) are significantly different (P < .05) when compared with the control.
Relative Weight (%) of Organs of Treated Rats and Control.a
| Dose (mg/kg) | Male | Female | ||
|---|---|---|---|---|
| Liver | Kidney | Liver | Kidney | |
| 0 | 3.00 ± 0.28 | 0.76 ± 0.12 | 3.24 ± 0.33 | 0.78 ± 0.33 |
| 111.42 | 3.20 ± 0.33 | 0.70 ± 0.00 | 3.20 ± 0.06 | 0.82 ± 0.33 |
| 222.84 | 3.00 ± 0.00 | 0.76 ± 0.03 | 3.00 ± 0.33 | 0.80 ± 0.03 |
| 445.68 | 3.20 ± 0.33 | 0.73 ± 0.03 | 3.80 ± 0.33 | 0.90 ± 0.03 |
a The results are mean ± standard error of the mean (SEM) (n = 5). Data in the same column in the same sex with asterisk (*) are significantly different (P < .05) when compared to the control.
Figure 2.Histological section of liver tissue (section stained with H&E, ×400). (a) Control. (b) Rats treated with dose of 222.84 mg/kg of Paullinia pinnata, without capillaries sinusoids dilatations. (c) Rats treated with dose of 445.68 mg/kg of P pinnata, with vascular congestion + slight capillaries sinusoids dilatations. (A) = male; (B) = female. CCLV. congestion of centrolobular vein; CLV, centrolobular vein; HP, hepatocites; CSD, capillaries sinusoids dilations; N, Necrosis; H&E, hematoxylin and eosin.
Figure 3.Histological section of kidney tissue (section stained with H&E, ×400) (a) Control. (b) Rats treated with dose of 222.84 mg/kg of Paullinia pinnata, without mesangial expansion. (c) Rats treated with dose of 445.68 mg /kg of P pinnata, with mesangial expansion. (A) = male; (B) = female. MEGl, mesangial expansion of glomerulus; UR, urinary room; Gl, glomerulus; H&E, hematoxylin and eosin.